Jonathan Schwartz

Jonathan Schwartz

Chief Tech/Sci/R&D Officer at ROCKET PHARMACEUTICALS, INC.

Net worth: 1 M $ as of 30/06/2026

62 year
Health Technology
Consumer Services
Health Services

Profile

Jonathan David Schwartz currently works at Rocket Pharmaceuticals, Inc., as Chief Medical & Gene Therapy Officer from 2024.
Dr. Schwartz also formerly worked at Eli Lilly & Co., as Vice President-Clinical Science, Stemline Therapeutics, Inc., as Vice President-Clinical Development from 2014 to 2016, The Mount Sinai Medical Center, Inc., as Associate Professor, and Rocket Pharmaceuticals Ltd., as Chief Medical Officer & Head-Clinical Development.
Dr. Schwartz received his doctorate degree from Washington University in St. Louis and undergraduate degree from Brown University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
18/11/2025 2,99,064 ( 0.27% ) 1 M $ 30/06/2026

Jonathan Schwartz active positions

CompaniesPositionStart
ROCKET PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 01/01/2016

Former positions of Jonathan Schwartz

CompaniesPositionEnd
STEMLINE THERAPEUTICS, INC. Corporate Officer/Principal 01/01/2016
Chief Tech/Sci/R&D Officer -
ELI LILLY AND COMPANY Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Jonathan Schwartz's experience

Training of Jonathan Schwartz

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

16

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Consumer Services

Health Technology

Consumer Services

Health Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Jonathan Schwartz